Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Law

Showing results (141-150 of 204) with videos related to

Pageof 21
Sort By:
Cancers|August 12, 2023
Adjuvant Chemotherapy in Older Patients with Gastric Cancer: A Population-Based Cohort StudyWing-Lok Chan, Xiaodong Liu, Carlos King-Ho Wong, et al.
Annals of Surgery|December 19, 2008
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodesChristian G Peyre, Jeffrey A Hagen, Steven R DeMeester, et al.
Theranostics|January 18, 2021
Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancerYun Zhu, Alfred K Y Lam, Daisy K Y Shum, et al.
Annals of Surgery|October 22, 2008
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resectionChristian G Peyre, Jeffrey A Hagen, Steven R DeMeester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasisSuet Y Leung, Xin Chen, Kent M Chu, et al.
International Journal of Cancer|September 30, 2010
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcomeStephen Ho Kin Chan, Josephine Mun Yee Ko, Kwok Wah Chan, et al.
Oncology Letters|February 14, 2018
Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patientsChung Man Chan, Kenneth K Y Lai, Enders K O Ng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 9, 2015
14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair moleculesKenneth K Y Lai, Kin Tak Chan, Mei Yuk Choi, et al.
Cancer Science|February 28, 2012
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progressionHiu-Fung Yuen, Cian M McCrudden, Claire Grills, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
Pageof 21

Showing results (141-150 of 204) with videos related to

Sort By:
Pageof 21
Cancers|August 12, 2023
Adjuvant Chemotherapy in Older Patients with Gastric Cancer: A Population-Based Cohort StudyWing-Lok Chan, Xiaodong Liu, Carlos King-Ho Wong, et al.
Annals of Surgery|December 19, 2008
Predicting systemic disease in patients with esophageal cancer after esophagectomy: a multinational study on the significance of the number of involved lymph nodesChristian G Peyre, Jeffrey A Hagen, Steven R DeMeester, et al.
Theranostics|January 18, 2021
Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancerYun Zhu, Alfred K Y Lam, Daisy K Y Shum, et al.
Annals of Surgery|October 22, 2008
The number of lymph nodes removed predicts survival in esophageal cancer: an international study on the impact of extent of surgical resectionChristian G Peyre, Jeffrey A Hagen, Steven R DeMeester, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2002
Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasisSuet Y Leung, Xin Chen, Kent M Chu, et al.
International Journal of Cancer|September 30, 2010
The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcomeStephen Ho Kin Chan, Josephine Mun Yee Ko, Kwok Wah Chan, et al.
Oncology Letters|February 14, 2018
Serum microRNA-193b as a promising biomarker for prediction of chemoradiation sensitivity in esophageal squamous cell carcinoma patientsChung Man Chan, Kenneth K Y Lai, Enders K O Ng, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|September 9, 2015
14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair moleculesKenneth K Y Lai, Kin Tak Chan, Mei Yuk Choi, et al.
Cancer Science|February 28, 2012
Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progressionHiu-Fung Yuen, Cian M McCrudden, Claire Grills, et al.
The British Journal of Surgery|February 12, 2025
Detecting residual disease after neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: The prospective multicentre preSINO trialYang Yang, Zhichao Liu, Ian Wong, et al.
Pageof 21